Literature DB >> 28647347

Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease.

Breanna M Scorza1, Mark A Wacker2, Kelly Messingham3, Peter Kim4, Aloysius Klingelhutz5, Janet Fairley6, Mary E Wilson7.   

Abstract

All Leishmania species parasites are introduced into mammalian skin through a sand fly bite, but different species cause distinct clinical outcomes. Mouse studies suggest that early responses are critical determinants of subsequent adaptive immunity in leishmaniasis, yet few studies address the role of keratinocytes, the most abundant cell in the epidermis. We hypothesized that Leishmania infection causes keratinocytes to produce immunomodulatory factors that influence the outcome of infection. Incubation of primary or immortalized human keratinocytes with Leishmania infantum or Leishmania major, which cause visceral or cutaneous leishmaniasis, respectively, elicited dramatically different responses. Keratinocytes incubated with L. infantum significantly increased expression of proinflammatory genes for IL-6, IL-8, tumor necrosis factor, and IL-1B, whereas keratinocytes exposed to several L. major isolates did not. Furthermore, keratinocyte-monocyte co-incubation studies across a 4 µM semipermeable membrane suggested that L. infantum-exposed keratinocytes release soluble factors that enhance monocyte control of intracellular L. infantum replication (P < 0.01). L. major-exposed keratinocytes had no comparable effect. These data suggest that L. infantum and L. major differentially activate keratinocytes to release factors that limit infection in monocytes. We propose that keratinocytes initiate or withhold a proinflammatory response at the site of infection, generating a microenvironment uniquely tailored to each Leishmania species that may affect the course of disease.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28647347      PMCID: PMC5786447          DOI: 10.1016/j.jid.2017.05.028

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  50 in total

1.  Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.

Authors:  F Y Liew; Y Li; S Millott
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

2.  Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation.

Authors:  S L Constant; K S Lee; K Bottomly
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

Review 3.  The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Authors:  Jan M Ehrchen; Cord Sunderkötter; Dirk Foell; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

4.  New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25.

Authors:  Stephen D Hurst; Tony Muchamuel; Daniel M Gorman; Jonathan M Gilbert; Theresa Clifford; Sylvia Kwan; Satish Menon; Brian Seymour; Craig Jackson; Ted T Kung; Joan K Brieland; Sandra M Zurawski; Richard W Chapman; Gerard Zurawski; Robert L Coffman
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

5.  Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut.

Authors:  Vanessa Diniz Atayde; Hamide Aslan; Shannon Townsend; Kasra Hassani; Shaden Kamhawi; Martin Olivier
Journal:  Cell Rep       Date:  2015-10-22       Impact factor: 9.423

Review 6.  Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis.

Authors:  Albert Schriefer; Mary E Wilson; Edgar M Carvalho
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

7.  Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.

Authors:  Francoise A Gourronc; mckaylee M Robertson; Annie K Herrig; Peter M Lansdorp; Frederick D Goldman; Aloysius J Klingelhutz
Journal:  Exp Dermatol       Date:  2009-06-23       Impact factor: 3.960

8.  Fibroblasts as host cells in latent leishmaniosis.

Authors:  C Bogdan; N Donhauser; R Döring; M Röllinghoff; A Diefenbach; M G Rittig
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

9.  Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice.

Authors:  M J McElrath; G Kaplan; A Nusrat; Z A Cohn
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice.

Authors:  Esther Von Stebut; Jan M Ehrchen; Yasmine Belkaid; Susanna Lopez Kostka; Katharina Molle; Jurgen Knop; Cord Sunderkotter; Mark C Udey
Journal:  J Exp Med       Date:  2003-07-14       Impact factor: 14.307

View more
  8 in total

1.  In vivo transcriptional analysis of mice infected with Leishmania major unveils cellular heterogeneity and altered transcriptomic profiling at single-cell resolution.

Authors:  Gopinath Venugopal; Jordan T Bird; Charity L Washam; Hayden Roys; Anne Bowlin; Stephanie D Byrum; Tiffany Weinkopff
Journal:  PLoS Negl Trop Dis       Date:  2022-07-05

Review 2.  Visceral Leishmaniasis and the Skin: Dermal Parasite Transmission to Sand Flies.

Authors:  Sahaana Arumugam; Breanna M Scorza; Christine Petersen
Journal:  Pathogens       Date:  2022-05-24

3.  TLR2 Signaling in Skin Nonhematopoietic Cells Induces Early Neutrophil Recruitment in Response to Leishmania major Infection.

Authors:  Catherine Ronet; Katiuska Passelli; Mélanie Charmoy; Leo Scarpellino; Elmarie Myburgh; Yazmin Hauyon La Torre; Salvatore Turco; Jeremy C Mottram; Nicolas Fasel; Sanjiv A Luther; Stephen M Beverley; Pascal Launois; Fabienne Tacchini-Cottier
Journal:  J Invest Dermatol       Date:  2018-12-27       Impact factor: 8.551

Review 4.  Cutaneous Manifestations of Human and Murine Leishmaniasis.

Authors:  Breanna M Scorza; Edgar M Carvalho; Mary E Wilson
Journal:  Int J Mol Sci       Date:  2017-06-18       Impact factor: 5.923

5.  Osteopontin in the host response to Leishmania amazonensis.

Authors:  Emilie Giraud; Eline Rouault; Laurence Fiette; Jean-Hervé Colle; Despoina Smirlis; Evie Melanitou
Journal:  BMC Microbiol       Date:  2019-02-08       Impact factor: 3.605

6.  Leishmania major degrades murine CXCL1 - An immune evasion strategy.

Authors:  Matthew S Yorek; Barun Poudel; Lalita Mazgaeen; R Marshall Pope; Mary E Wilson; Prajwal Gurung
Journal:  PLoS Negl Trop Dis       Date:  2019-07-01

7.  In situ cellular immune response in non-ulcerated skin lesions due to Leishmania (L.) infantum chagasi infection.

Authors:  Carmen Sandoval; Gabriela Araujo; Wilfredo Sosa; Sara Avalos; Fernando Silveira; Carlos Corbett; Concepción Zúniga; Marcia Laurenti
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-02-26

Review 8.  The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection.

Authors:  Katiuska Passelli; Oaklyne Billion; Fabienne Tacchini-Cottier
Journal:  Front Immunol       Date:  2021-03-01       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.